ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT NUCLEATING AGENTS

Abstract: Disclosed are anhydrous antiperspirant compositions comprising from about 0.5 % to about 60 % by weight of particulate antiperspirant active; from about 1 % to about 15 % by weight of a solid non-polymeric gellant; from about 10 % to about 80 % by weight of an anhydrous liquid carrier having an average solubility parameter of from about 3 to about 13 (cal/cm<3>)<0.5>; and from about 0.0001 % to about 5.0 % by weight of a solid nucleating agent wherein the molar ratio of the solid non-polymeric gellant to the nucleating agent is from about 10:1 to about 1000:1. These antiperspirant compositions provide improved low residue performance and improved antiperspirant efficacy.

Description: ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT NUCLEATING AGENTS FIELD OF THE INVENTION The present invention relates to antiperspirant compositions having improved low residue and efficacy performance, and which contain select nucleating agents in combination with a crystalline gellant. BACKGROUND OF THE INVENTION There are many types of topical antiperspirant products that are commercially available or otherwise known in the antiperspirant art. Most of these products are formulated as aerosol or pump sprays, roll-on liquids, creams, emulsions, gels, gel-solids, or other solid stick formulations, and comprise an astringent material, e.g. zirconium or aluminum salts or combinations thereof, incorporated into a suitable carrier. These products are designed to provide effective perspiration and odor control while also being cosmetically acceptable during and after application onto the axillary area or other areas of the skin. Within this product group, solid antiperspirant sticks have become especially popular among consumers. These antiperspirant sticks comprise a solid matrix within which the antiperspirant active material is contained. The active can be solubilized in a liquid carrier comprising water, glycols and/or other alcohols, or maintained within a solid matrix as dispersed solids in an anhydrous system. The solid sticks which contain dissolved active often provide some low residue performance, but tend to be wet or sticky during and immediately after application to the skin, and more importantly, are often not as effective in providing antiperspirant and deodorant performance as solid sticks containing dispersed paniculate active. Although the antiperspirant sticks which contain particulate actives are more effective, they also tend to leave a higher visible residue on the skin. There have been many attempts at producing anhydrous antiperspirant sticks which contain dispersed particulate antiperspirant active, and which also provide improved efficacy and low residue performance during and after application to the skin, or which otherwise provide product clarity prior to (as a packaged product) or after such application (as a clear or low-residue film on the skin). One such attempt involves the combination of particulate antiperspirant active, gellants and liquid carrier in a gel stick, wherein all such components in the combination have matching refractive indices. Refractive index matching allows for more passage of light through the gel stick with less scattering of the light, thus resulting in products which appear more clear or translucent as a packaged composition or when initially applied topically to the skin. These gel sticks, however, are expensive to make due to the cost of using raw materials having only select matching refractive indices. These compositions are also very difficult to formulate given that refractive index matching for a three component system (particulate active, solvent and gellant) is extremely difficult, and greatly limits the materials that can be used to prepare such a formulation. Another attempt at making low residue antiperspirant sticks involves the use of gellants such as dibenzylidene alditols. These gellants, however, like many other gellants known in the art, are not acid stable and therefore tend to interact with the antiperspirant active due to the acidic nature of the active. This interaction can result in reduced efficacy of the active, poor gel formation, and lower gel stability over extended periods during shipping or storage. This interaction may also cause processing difficulties at the temperatures and holding times often used during the formulation and manufacturing process. These gellants are also commonly used in combination with glycol carriers or other solvents which tend to be wet and sticky and irritating to the skin. Yet another attempt at making low residue antiperspirant sticks involves the use of residue masking agents such as non-volatile paraffinic hydrocarbon fluids, phenyl trimethicone, low melting point waxes and combinations thereof. These agents are used in combination with stearyl alcohol or other high residue waxes commonly used in solid antiperspirant sticks. These agents help reduce visible residue during and immediately after application of the solid stick to the skin, but also tend to be associated with an oily or sticky skin feeling during application. Moreover, although the visible residue is reduced in such compositions, there remains a visible residue on the skin when used in combination with high residue waxes such as stearyl alcohol, and this reduced residue is still more visible or apparent than the topical residue left by antiperspirant sticks which contain solubilized antiperspirant active. Other attempts at improving low residue performance from an antiperspirant composition has focused on the use of anhydrous antiperspirant creams. These creams can be applied to the skin by conventional means, or by a cream applicator device, and results in very low residue during and immediately after application to the skin. These compositions comprise particulate active dispersed throughout an anhydrous carrier, and either contained within a solid-like matrix or thickened with an inorganic or polymeric gellant or thickening agent. Many consumers, however, still prefer the convenience of using a solid antiperspirant stick, even if the solid stick tends to leave a higher visible residue on the skin. A recent method of making low residue antiperspirant sticks is described in U.S. Patent 5,429,816, issued to Hofrichter et al. on July 4, 1995, which description is hereby incorporated by reference herein. The antiperspirant sticks provide low visible residue during and immediately after application to the skin, and are physically and chemically stable over extended periods of time. The improved antiperspirant sticks comprise a dual gellant system having a primary gellant such as 12- hydroxystearic acid or esters or amides thereof and a secondary gellant such as n-acyl amino acid amides. Formation of such an antiperspirant stick with such a dual gellant system has been characterized as a "gel- solid" antiperspirant stick. An antiperspirant gel-solid, such as that described by Hofrichter et. al., is an antiperspirant stick having a three-dimensional, non-polymeric, gel network in which solvent is contained or trapped. These gel-solids are typically formed by solubilizing the gellant in the solvent at temperatures above the melt point of the gellant and at temperatures at which the melted gellant is soluble in the solvent, and then cooling the composition to form the desired gel-solid composition. The low residue gel-solids described by Hofrichter et al. are remarkably stable, both physically and chemically, and will maintain the desired product hardness over an extended period of time. The gel-solids described by Hofrichter et al., however, are limited to select dual gellant systems and do not include or otherwise describe any method of making a low-residue antiperspirant gel-solid stick containing any other gellant or gellant system. It has now been found that improved antiperspirant compositions can be formulated using a single crystalline gellant or a combination of crystalline gellants in combination with select nucleating agents to help minimize gellant crystalline particle size. The smaller gellant crystalline particle sizes made possible by such combinations result in antiperspirant compositions having lower visible residue when applied topically to the skin. It has been found that the crystalline matrix of such compositions causes less scattering of light, thus providing the appearance of reduced residue when such a composition is applied to the skin. Moreover, the small crystalline particles from the composition more easily melt when applied to the skin, thus forming a topical fluid or liquid layer on the applied surface that further provides the appearance of reduced residue. The select nucleating agents as defined herein are especially useful when used in combination with solid non-polymeric crystalline gellants. These compositions may be formulated as liquids, soft-gels, or harder gel-solids. It is therefore an object of the present invention to provide an anhydrous antiperspirant composition having improved hardness and low visible residue, and further to provide such a composition which contains crystalline gellants in combination with a nucleating agent. It is a further object of the present invention to provide such a composition that contains a single crystalline gellant or a combination of crystalline gellants in combination with a nucleating agent. It is yet another object of the present invention to provide such a composition that is physically and chemically stable over extended periods of time, and further to provide an anhydrous gel stick composition containing a gelling agent which is stable in the presence of a particulate antiperspirant active. SUMMARY OF THE INVENTION The present invention is directed to an anhydrous antiperspirant composition comprising from about 0.5% to about 60% by weight of particulate antiperspirant active; from about 1% to about 15% by weight of a solid non-polymeric gellant; from about 10% to about 80% by weight of an anhydrous liquid carrier for the solid non-polymeric gellant having an average solubility parameter of from about 3 to about 13 (cal/cm 3 ) 0 - 5 ; and from about 0.0001% to about 5% by weight of select nucleating agents wherein the molar ratio of the solid non-polymeric gellant to the nucleating agent is from 10: 1 to about 1000: 1. The nucleating agent preferably has a melt point near the melt point of the solid non-polymeric gellant, a solubility in the nonaqueous liquid carrier which is less than the solubility of the solid non- polymeric gellant in the nonaqueous liquid carrier, or is in the form of inorganic, micronized particles. It has now been found that this combination of solid non-polymeric gellant and the select nucleating agents helps minimize gellant particle size in the composition, which then results in an antiperspirant composition having lower visible residue when applied topically to the skin. It has been found that the crystalline matrix arising from such compositions causes less scattering of light due to the smaller gellant particle size, thus providing the appearance of reduced residue when the composition is applied to the skin. Moreover, the small crystalline particles from the composition more easily melt when applied to the skin, thus forming a topical fluid or liquid layer on the applied surface that further provides the appearance of reduced residue. The select nucleating agents as defined herein are especially useful when used in combination with the solid non-polymeric crystalline gellants. DETAILED DESCRIPTION OF THE INVENTION The antiperspirant gel-solid stick compositions of the present invention are anhydrous systems which are dispersions of particulate antiperspirant active held or contained within a non-polymeric crystalline gel-solid matrix. The term "anhydrous" as used herein means that the antiperspirant gel-solid stick composition of the present invention, and the essential or optional components thereof other than the particulate antiperspirant active, are substantially free of added or free water. From a formulation standpoint, this means that the antiperspirant gel-solid stick compositions of the present invention preferably contain less than about 5%, preferably less than about 3%, more preferably less than about 1%, most preferably zero percent, by weight of free or added water, other than the water of hydration typically associated with the particulate antiperspirant active prior to formulation. The term "low residue" as used herein refers generally to the visible residue left on the applied areas of the skin during or immediately after application, and more specifically refers to the visible residue index of the composition as defined by the methodology described hereinafter. The term "ambient conditions" as used herein refers to surrounding conditions under about one atmosphere of pressure, at about 50% relative humidity, and at about 25°C, unless otherwise specified. The term "substituted" as used herein, unless otherwise specified, refers to chemical moieties or substituents known or otherwise suitable for attachment to the compounds or other chemical materials described or referred to herein. These substituents include, but are not limited to, those listed and described in C. Hansch and A. Leo, Substituent Constants for Correlation Analysis in Chemistry and Biology (1979), which listing and description are incorporated herein by reference. Examples of such substituents include, but are not limited to, alkyl, alkenyl, alkoxy, hydroxy, oxo, nitro, amino, aminoalkyl (e.g., aminomethyl, etc.), cyano, halo (e.g., chlorine, fluorine, bromine, iodine), carboxy, alkoxyaceyl (e.g., carboethoxy, etc.), thiol, aryl, cycloalkyl, heteroaryl, heterocycloalkyl (e.g., piperidinyl, morpholinyl, pyrrolidinyl, etc.), imino, thioxo, hydroxyalkyl, aryloxy, arylalkyl, amides, esters, ethers, combinations thereof, and the like. The terms "alkyl" and "alkenyl" as use herein, unless otherwise specified, refer to substituted or unsubstituted, branched, cyclic or linear, hydrocarbons having from 1 to about 22 carbon atoms. The term "n-acyl amino acid derivatives" as used herein refers to gellants selected from the group consisting of n-acyl amino acid amides, n-acyl amino acid esters prepared from glutamic acid, lysine, glutamine, apartic acid, and combinations thereof, and which are specifically disclosed in U.S. Patent 5,429,816. The term "volatile" as used herein refers to materials which have a vapor pressure under ambient conditions of at least about 0.2 mm of Hg. Conversely, the term "non-volatile" as used herein refers to materials which have no measurable vapor pressure or which have a vapor of less than about 0.2 mm of Hg under ambient conditions. The solid non-polymeric gellant, antiperspirant active and anhydrous liquid carrier components of the gel-solid stick composition herein are preferably not refractive index matched, and more preferably have at least two of such components with refractive indices (η 0 ) that differ by at least about 0.02, more preferably by at least about 0.04. The term "non-polymeric" as used herein does not mean polymeric derivatives of 12-hydroxystearic acid, and combinations thereof. The antiperspirant gel-solid stick compositions of the present invention can comprise, consist of, or consist essentially of the essential elements and limitations of the invention described herein, as well as any of the additional or optional ingredients, components, or limitations described herein. As percentages, parts and ratios are by weight of the total composition, unless otherwise specified. All such weights as they pertain to listed ingredients are based on the specific ingredient level and, therefore, do not include solvents, carriers, by-products, filler or other minor ingredients that may be included in commercially available materials, unless otherwise specified. Product Characteristics The antiperspirant gel-solid stick compositions of the present invention are preferably characterized in terms of product hardness, visible residue index, and a rheology profile defined by a ratio of an elastic to viscous moduli. Each of these characteristics is defined in accordance with the methodologies and other limitations described hereinafter. a) Hardness The antiperspirant gel-solid stick compositions of the present invention preferably have a product hardness of from about 500 gram-force to about 5,000 gram-force, more preferably from about 750 gram- force to about 2,000 gram-force, even more preferably from about 800 gram-force to about 1,400 gram- force. The term "product hardness" as used herein is a reflection of how much force is required to move a penetration cone a specified distance and at a controlled rate into an antiperspirant gel-solid stick composition under the following test conditions. Higher values represent harder product, and lower values represent softer product. These values are measured at 27°C, 15% relative humidity, using a TA- XT2 Texture Analyzer, available from Texture Technology Corp., Scarsdale, New York, U.S.A. The product hardness value as used herein represents the amount of force required to move a standard 45° angle penetration cone through the composition for a distance of 1 Omm at a rate of 2mm/second. The standard cone is available from Texture Technology Corp., as part number TA-15, and has a total cone length of about 24.7 mm, angled cone length of about 18.3 mm, a maximum diameter of the angled surface of the cone of about 15.5 mm. The cone is a smooth, stainless steel construction and weighs about 17.8 grams. b) Residue The antiperspirant gel-solid stick compositions of the present invention preferably have a visible residue index of from 1 1 to about 30 L-value, more preferably from about 1 1 to about 25 L-value, even more preferably from 1 1 to about 20 L-value. The term "visible residue index" as used herein refers generally to the extent to which the composition of the present invention is visibly apparent as a thin topical film after application to the skin, and more specifically refers to measured visible residue values (expressed as an L-value on the L, a, b color scale) in accordance with the following methodology, performed at 27°C, under atmospheric pressure, and at 15% relative humidity on antiperspirant stick compositions having a product hardness of from about 500 gram-force to about 5,000 gram-force. A piece of black felt, approximately 10 cm x 30 cm, is attached to a movable horizontal slide which is movably attached or fixed to a larger mechanical unit. An example of a suitable piece of black felt for use herein is Supreme Robe Velour, FN-6554, Color 404L, Style 31854, available from So-Fro Fabrics, Evendale, Ohio, U.S.A. An example of a suitable mechanical assembly for use herein is the Release and Adhesion Tester, Serial No. A-14934, manufactured by Testing Machines, Inc., Amityville, New York, U.S.A., or a Velmex Unislide Positioning System, Unislide assembly series (MB6000), available from Velmex, Inc., Bloomfield, New York, U.S.A. An antiperspirant stick composition contained within and partially extending out about 0.5 cm from a conventional package or container is positioned perpendicular to and above the attached piece of felt, such that the product extending out of the package or container is facing the piece of felt and the surrounding package is positioned away from the piece of felt. The surrounding package is positioned in place using a mechanical arm or other device suitable for applying the requisite movement to the product as described herein. The antiperspirant stick composition is then slowly moved toward and allowed to gently contact the attached piece of black felt. A 1,000 gram weight is placed on the product sample so that the product continuously contacts the piece of black felt during testing. The weighted sample is then moved repeatedly back and forth across the piece of felt at a fixed speed (about 3 cm/second), and with a fixed amount of applied pressure provided by the weighted product, until about 1.75 grams of the antiperspirant stick composition is evenly applied over a 5 cm x 20 cm area of the piece of black felt. The piece of felt is then carefully removed from the apparatus. - 1 ■ A calibrated Minolta CR-300 chromameter (available from Minolta Corp., Ramsey, New Jersey, U.S.A.) is then used to measure the L-value (on the L,a,b color scale) of the applied surface area. First, a template is placed on top of the piece of felt to facilitate the Minolta readings. Template dimensions are 5 cm x 20 cm. The template has twelve circular openings (2.2 cm diameter) positioned within the template, each opening positioned centrally within adjacent 6.5 cm^ areas of the template surface. The template is positioned over the applied surface area of the piece of felt such that each of the twelve circular openings covers a non-overlapping area of the applied surface. The chromameter's view port is fitted into each of the circular openings and L-value measurements taken. An average L-value is then determined for the twelve measurements (standard deviation of less than about 0.8) which then corresponds to the visible residue index as described herein. It has been found that there is a correlation between the visible residue index range defined herein and the average particle size of the crystalline gellant particles in the antiperspirant gel-solid stick composition of the present invention. Generally, as the average particle size of crystalline gellant particles in the composition decreases, low residue performance improves. In particular, it has been found that a visible residue index of from about 1 1 to about 30 L-value correlates with an average crystalline gellant particle size of less than about 1 μm, and/or a crystalline gellant particle morphology characterized by one dimensional crystalline growth such as that resulting in crystalline filaments, fibers, strings or other elongated particles, wherein the aspect ratio as defined by the major and minor axis of the crystalline particle is greater than about 2, preferably greater than about 6. Conversely, solid compositions containing crystalline gellant particles greater than 1 μm (average particle diameter) have a visible residue index of greater than 30 L-value. In view of this correlation between visible residue index values and average crystalline particle size or elongated particle morphology, the visible residue index measurement can now be used as an alternative means for establishing average crystalline gellant particle size or crystalline gellant morphology, at least to the extent that such average particle size is less than about 1 μm. c) Rheology The antiperspirant stick compositions of the present invention are gel-solids having the select rheology profile defined herein. This rheology profile is defined herein in terms of the elastic (G') to viscous (G") moduli ratio ( G' / G" ) of the gel-solid stick composition. To provide the requisite rheology, the gel-solid stick compositions must have a G' / G" ratio of from about 0.1 to about 100, preferably from about 0.1 to about 50, more preferably from about 1 to about 20, even more preferably from about 5 to about 20. This ratio represents the extent to which the gel-solid stick compositions herein exhibit solid character and the extent to which the compositions exhibit liquid or fluid character, and specifically refers to the numerical ratio G' / G" as determined by the following methodology. The elastic modulus is a measurement which correlates with the solid character of the gel-solid stick compositions herein, and the viscous modulus is a measurement which correlates with the fluid or liquid character of the gel-solid stick compositions herein. Measurements for G' and G" for purposes of defining the composition of the present invention are determined under ambient conditions using conventional techniques well known in the formulation arts. For example, a Bohlin Stress-Strain Rheometer, available from Bohlin Reologi, Cranberry, New Jersey, can be used using a cone (about 1°) and plate configuration. About 1.0 mg of the product is carefully removed for the composition with minimal application of shear force and is then placed between the cone and plate fixtures for measurement of G' and G". It has been found that the gel-solid stick compositions of the present invention exhibit improved low residue performance when formulated as described herein, wherein the composition has the select G'/G" ratio described hereinabove, especially when the defined rheology is associated with a crystalline gel matrix having a preferred small particle size and/or particle morphology as described herein. These gel-solid stick formulations spread smoothly over the skin, and shear quickly and melt during such spreading to form a thin, low residue film over the applied surface. In particular, it has been found that the gel-solid stick compositions of the present invention have rheology characteristics that result in improved performance, especially low residue performance. These select gel-solid compositions as defined herein behave as solids prior to application while maintained within a canister or other package, but behave more as liquids or fluids during or immediately after application to the skin. In other words, the solid compositions shear thin during application to the skin, melt or almost melt (except for particulate active which remains unmelted) during the shear thinning application, thus resulting in a thin, low residue, liquid or fluid film on the skin during or immediately after topical application to the skin. The applied film is clear or has very low visible residue, and remains substantially as such over extended periods of time after application. Antiperspirant Active The antiperspirant gel-solid stick compositions of the present invention comprise particulate antiperspirant active suitable for application to human skin. These particulate actives must remain substantially unsolubilized as dispersed or precipitated solids in the anhydrous or substantially anhydrous systems as described herein. The concentration of particulate active in the composition should be sufficient to provide the desired perspiration wetness and odor control from the antiperspirant gel-solid stick formulation selected. The antiperspirant gel-solid stick compositions of the present invention preferably comprise particulate antiperspirant active at concentrations of from about 0.5% to about 60%, more preferably from about 5% to about 35%, by weight of the composition. These weight percentages are calculated on an anhydrous metal salt basis exclusive of water and any complexing agents such as glycine, glycine salts, or other complexing agents. The particulate antiperspirant active as formulated in the composition are in the form of dispersed solid particles having a preferred average particle size or diameter of less than about 100 μm, more preferably from about 15 μm to about 100 μm, even more preferably from about 20 μm to about 100 μm. Also preferred are dispersed solid particulates having an average particle size or diameter of less than about 2 μm, even more preferably from less than about 0.4 μm. It has been found that antiperspirant active particles within the preferred particle size ranges provide lower visible residue performance from the gel-solid compositions herein than other less preferred particle size ranges. The antiperspirant active for use in the antiperspirant gel-solid stick compositions of the present invention include any compound, composition or other material having antiperspirant activity. Preferred antiperspirant actives include the astringent metallic salts, especially the inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof. Particularly preferred are the aluminum and zirconium salts, such as aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof. Preferred aluminum salts for use in the antiperspirant gel-solid stick compositions include those which conform to the formula: Al 2 (OH) a Cl b - x H 2 0 wherein a is from about 2 to about 5; the sum of a and b is about 6; x is from about 1 to about 6; and wherein a, b, and x may have non-integer values. Particularly preferred are the aluminum chlorhydroxides referred to as "5/6 basic chlorhydroxide", wherein a = 5, and "2/3 basic chlorhydroxide", wherein a = 4. Processes for preparing aluminum salts are disclosed in U.S. Patent 3,887,692, Gilman, issued June 3, 1975; U.S. Patent 3,904,741, Jones et al., issued September 9, 1975; U.S. Patent 4,359,456, Gosling et al., issued November 16, 1982; and British Patent Specification 2,048,229, Fitzgerald et al., published December 10, 1980, all of which are incorporated herein by reference. Mixtures of aluminum salts are described in British Patent Specification 1,347,950, Shin et al., published February 27, 1974, which description is also incorporated herein by reference. Preferred zirconium salts for use in the antiperspirant gel-solid stick compositions include those which conform to the formula: ZrO(OH) 2 . a Cl a ■ x H 2 0 wherein a is from about 1.5 to about 1.87; x is from about 1 to about 7; and wherein a and x may both have non-integer values. These zirconium salts are described in Belgian Patent 825,146, Schmitz, issued August 4, 1975, which description is incorporated herein by reference. Particularly preferred zirconium salts are those complexes which additionally contain aluminum and glycine, commonly known as ZAG complexes. These ZAG complexes contain aluminum chlorhydroxide and zirconyl hydroxy chloride conforming to the above described formulas. Such ZAG complexes are described in U.S. Patent 3,679,068, Luedders et al., issued February 12, 1974; Great Britain Patent Application 2, 144,992, Callaghan et al., published March 20, 1985; and U.S. Patent 4,120,948, Shelton, issued October 17, 1978, all of which are incorporated herein by reference. The antiperspirant gel-solid stick compositions of the present invention can also be formulated to comprise other dispersed solids or other materials in addition to or in place of the particulate antiperspirant active. Such other dispersed solids or other materials include any material known or otherwise suitable for topical application to human skin. The antiperspirant gel-solid stick compositions can also be formulated as gel-solid stick compositions which contain no antiperspirant or other active material, particulate or otherwise. Gellant The antiperspirant compositions of the present invention comprise a solid non-polymeric gellant suitable for topical application to human skin. These solid non-polymeric gellants must form within the composition a crystalline matrix within which an anhydrous liquid carrier or other liquid component of the composition is trapped or contained. These solid non-polymeric gellants preferably form crystalline particles having an average particle diameter and particle morphology as described hereinafter. The antiperspirant compositions may comprise, but are preferably substantially free of, gellants such as dibenzylidene alditols and fatty alcohol gellants or nucleating agents (described hereinafter) having from about 12 to 40 carbon atoms including stearyl alcohol. In this context, "substantially free" means that the compositions preferably contain less than an effective amount of such agents that when used alone would provide any thickening or measurable viscosity increase to the composition under ambient conditions. Generally, the compositions preferably contain less than 5%, more preferably less than 1%, more preferably less than 0.5%, most preferably zero percent, of such agents by weight of the composition. The concentration of the solid non-polymeric gellants in the compositions may vary with each selected antiperspirant formulation, especially with each selected anhydrous liquid carrier of the formulation, but such concentrations will generally range from about 0.1% to about 20%, preferably from about 1% to about 15%, more preferably from about 3% to about 12%, by weight of the composition. The non-polymeric gellants must be solids under ambient conditions. The solid non-polymeric gellants for use in the antiperspirant compositions are those which can melt and form a solution or other homogenous liquid or liquid dispersion with the selected anhydrous liquid carrier, and at the selected gellant and liquid carrier concentrations, at a processing temperature of from about 28°C to about 250°C, preferably from about 28°C to about 100°C, more preferably from about 28°C to about 78°C. The melted non-polymeric gellant is typically dissolved by or dispersed throughout the selected liquid carrier to thus form a solution or other homogenous liquid. The solution or other homogenous liquid, and other essential and optional ingredients, are preferably combined in accordance with the manufacturing method described herein or other conventional or otherwise known technique, and then placed in a suitable package as a flowable solution or homogenous liquid, and then allowed to solidify (for non-liquid embodiments of the present invention) and form the desired crystalline gel matrix within the composition as the temperature returns to ambient temperature and drops to below the solidification point of the selected non-polymeric gellant. In selecting a combination of solid non-polymeric gellant and liquid carrier for use in the antiperspirant gel-solid stick compositions, the selected combination should allow for the development of a crystalline gellant matrix within the composition wherein the component crystalline particles preferably have an average particle size of less than about 1 μm, more preferably less than about 0.4 μm, even more preferably less than about 0.2 μm, most preferably from about 0.001 μm to about 0.2 μm, and/or wherein the crystalline particles have the requisite elongated morphology described herein, wherein particle size is measured or determined by the methods described herein or by methods well-known to those skilled in the art such as light or electron microscopy. The gel-solid stick compositions can be prepared by methods well known in the formulation art for making gel-solids having minimal crystalline particle size or the preferred elongated particle morphology. The gel-solid stick compositions are preferably prepared by the select methods described hereinafter directed to minimizing crystalline particle size and/or establishing the preferred crystalline particle morphology. Solid non-polymeric gellants suitable for use in the antiperspirant compositions of the present invention include fatty acid gellants, esters and amides of fatty acid gellants, hydroxy acids, hydroxy fatty acids, cholesterolic materials, lanolinolic materials, and other amide gellants known for use as gelling agents of which are otherwise described in detail hereinafter. The solid non-polymeric gellants can be used as a single gellant or as a combination of gellants in combination with the select nucleating agent. Other crystalline gellants can also be used in the antiperspirant compositions of the present invention provided that such other gellants can be formulated with the selected nucleating agent to provide the requisite crystalline gel matrix. Suitable amide gellants include disubstituted or branched monoamide gellants, monosubstituted or branched diamide gellants, triamide gellants, n-acyl amino acid derivatives, and combinations thereof. Non-limiting examples of suitable secondary amide gellants include select alkyl amides of a di- and/or tri-basic carboxylic acids which conform to the formula: R Q O 1 9 II R , — c — c - — N — R 2 a R 3 — X _ Y — ? Z' — R , o 1 II R C — C - N ~ R 4 1 1 1 1 R 10 R 6 wherein a backbone is formed from the linkage of C, C" and X and wherein a) R j is nil, hydroxy, hydrogen, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C j -C alkyl, C \ - C alkenyl, Cj-C alkoxy, C j -C 22 alkyl esters, C j -C 2 alkyl ethers, or C j - C alkyl substituted aryl, preferably C4-CJ 8 alkyl, C4-C 13 alkenyl, C4-C j g alkoxy, C4-C ] g alkyl esters, C4-Cι g alkyl ethers, or C4-C j g alkyl substituted aryl, more preferably Cι -C j g alkyl, C j -C j g alkenyl, C^-C j g alkoxy, C ι 2 - C 18 alkyl esters, Cj 2 -Cι alkyl ethers, or C 12 -Cι alkyl substituted aryl; b) R 2 , R4, R5 and Rg are independently or together, hydrogen, hydroxy, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain Cι-C 2 2 alkyl, C j -C 22 alkenyl, Cι>C 22 alkoxy, Cι-C 2 alkyl esters, Cj-C 22 alkyl ethers, or C j -C 22 alkyl substituted aryl, preferably C4- C10 alkyl, C4-C 10 aLkenyl, C 4 -C JO alkoxy, C4-C10 alkyl esters, C4-C10 alkyl ethers, or C4-C10 alkyl substituted aryl, more preferably C4-Cg alkyl, C4-Cg alkenyl, C4-Cg alkoxy, C4-Cg alkyl esters, C4-C alkyl ethers, or C4-Cg alkyl substituted aryl; c) R3 is nil, hydroxy, hydrogen, saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C J-C4 alkyl, C1 -C4 alkenyl, C j - C4 alkoxy, CJ-C4 alkyl esters or CJ-C4 alkyl ethers, preferably a C 1-C4 alkoxy, hydroxy or hydrogen, more preferably ahydroxy or hydrogen; d) R7 and Rg are independently or together, nil, hydrogen, hydroxy, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C j -C 22 alkyl, C j -C 22 alkenyl, C j -C 22 alkoxy, C j -C 22 alkyl esters, C | -C 22 alkyl ethers, or Cι-C 22 alkyl substituted aryl, preferably C4-CJ0 alkyl, C4-C10 alkenyl, C4-CJ0 alkoxy, C4-C10 alkyl esters, C4-C 10 alkyl ethers, or C4-C10 alkyl substituted aryl, more preferably C4-Cg alkyl, C4-Cg alkenyl, C4- Cg alkoxy, C4-C alkyl esters, C4-Cg alkyl ethers, or C4-C alkyl substituted aryl; e) R9 is nil or hydrogen; f) RJO and R j j are independently or together, nil, hydrogen, hydroxy, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain Ci -Cg alkyl, C j -Cg alkenyl, C j -Cg alkoxy, Ci -Cg alkyl esters, C j - Cg alkyl ethers, or C j -Cg alkyl substituted aryl, preferably CJ-C4 alkyl, C1-C4 •alkenyl, C1-C4 alkoxy, C1-C4 alkyl esters, C1 -C4 alkyl ethers, C1-C4 alkyl substituted aryl or hydrogen, more preferably a hydrogen; g) X is nitrogen, aryl or ~ ^"^ n where n is an integer from 1 to 6, preferably ~ ^"^2 n where n is an integer from 1 to 3; h) Y is nil, acyl or carbonyl; i) Z is nil, hydrogen, hydroxy, aryl, siloxane, nitrogen or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C 1 -C 2 alkyl, C t - C 22 alkenyl, C]-C 22 alkoxy, Cj-C 2 2 alkyl esters, C j -C 2 alkyl ethers, or C\- C 22 alkyl substituted aryl, preferably C4-C10 alkyl, C4-CJ0 alkenyl, C4-CJ0 alkoxy, C4-C 10 alkyl esters, C4-C10 alkyl ethers, or C4-CJ0 alkyl substituted aryl, more preferably C4-Cg alkyl, C4-Cg alkenyl, C4-C alkoxy, C4-C alkyl esters, C4-Cg alkyl ethers, or C4-Cg alkyl substituted aryl; and j) "a" is a double or single bond provided: (i) when X and Z are not nil and Y is nil, X is directly bonded to Z; (ii) when Z is nil, a hydrogen or ahydroxy, R7 and Rg are nil; and (iii) when "a" is a double bond, R3 and RQ are nil. Some specific examples of suitable alkyl amides of di- and tri-basic carboxylic acids include, but are not limited to, alkyl amides of citric acid, tricarballylic acid, aconitic acid, nitrilotriacetic acid and itaconic acid such as 1,2,3-propane tributylamide, 2-hydroxy-l,2,3-propane tributylamide, 1-propene- 1,2,3-trioctylamide, N,N',N"-tri(methyldecylamide)amine, 2 docecyl-N,N'-dibutylsuccinamide, and combinations thereof. Preferred are alkyl amides di-carboxylic acids, more preferably 2 docecyl-N,N'- dibutylsuccinamide. Suitable n-acyl amino acid derivatives include, but are not limited to, N-lauroyl-glutamic acid diethyl amide, N-lauroyl-glutamic acid dibutyl amide, N-lauroyl-glutamic acid dihexyl amide, N-lauroyl- glutamic acid dioctyl amide, N-lauroyl-glutamic acid didecyl amide, N-lauroyl-glutamic acid didodecyl amide, N-lauroyl-glutamic acid ditetradecyl amide, N-lauroyl-glutamic acid dihexadecyl amide, N- lauroyl-glutamic acid distearyl amide, N-stearoyl-glutamic acid dibutyl amide, N-stearoyl-glutamic acid dihexyl amide, N-stearoyl-glutamic acid diheptyl amide, N-stearoyl-glutamic acid dioctyl amide, N- stearoyl-glutamic acid didecyl amide, N-stearoyl-glutamic acid didodecyl amide, N-stearoyl-glutamic acid ditetradecyl amide, N-stearoyl-glutamic acid dihexadecyl amide, and N-stearoyl-glutamic acid distearyl amide. Preferred are n-lauroyl-glutamic acid dibutyl amide, n-stearyl-glutamic acid dihexyl amide, and combinations thereof. The select alkyl amide gellants are preferably synthesized by direct amidation of the corresponding di- or tri-basic organic acid with the appropriate alkyl amine under suitable reaction temperatures, followed by removal of excess amine from the resulting mixture containing the alkylated amide gellants. The select alkyl amide gellants may also be synthesized by esterification of the corresponding di- or tri-basic organic acid with methanol using a boron trifluoride catalyst followed by removal of the excess methanol and catalyst. The resulting trimethyl ester is then amidated using the appropriate alkylamine followed by removal of excess amine. The resulting alkyl amides for use in the composition should be non-polymeric. Suitable fatty acid gellants include, but are not limited to, hydroxy fatty acids including alpha- hydroxy acids and 12-hydroxystearic acid and derivatives thereof (including amides and esters thereof), fatty acids having from about 10 to about 40 carbon atoms (e.g., behenic acid, eurcic acid, stearic acid) and related gellants, some preferred examples of which are disclosed in U.S. Patent 5,429,816, issued to Hofrichter et al. on July 4, 1995; and U.S. Patent 5,552,136, issued to Motley on September 3, 1996, both disclosures of which are incorporated by reference herein. Preferred are 12-hydroxystearic acid and derivatives thereof. These solid non-polymeric gellants described herein are especially effective when used in combination with select anhydrous carriers such as volatile silicones, especially volatile cyclomethicone. These gellants are most preferably used in combination with a liquid carrier comprising a volatile silicone and a non-volatile silicone (e.g., non-volatile dimethicones or other organofunctional siloxanes well known in the art) and/or a non-volatile organic carrier. Preferred enantomeric gellants Preferred solid non-polymeric gellants for use herein include those enantomeric compounds or materials containing at least one asymmetric (chiral) carbon atom. Non-limiting examples of these preferred enantomeric gellants include 12-hydroxystearic acid, other hydroxy acids such as alpha hydroxy acids, cholesterols, lanolin, and derivatives thereof. It has been found that these preferred enantomeric gellants, when used in the anhydrous antiperspirant gel-solid stick compositions herein, provide the composition with the requisite product hardness, visible residue index values and rheological properties (G 1 / G"). It is believed that these enantomeric gellants are especially effective in forming one-dimensional elongated particles in the form of filaments, fibrils or strings which are intertwined or twisted to form a stable, three-dimensional crystalline matrix in the gel-solid composition. These elongated particles have an aspect ratio of greater than about 2, preferably greater than about 6. It is believed that these gellants form elongated crystalline particles that result in a stable crystalline matrix that, in part because of the small size and elongated moφhology of these particles, cause less scattering of light when applied to the skin in the antiperspirant composition, which then results in low visible residue after such application. Preferred particle morphology The solid non-polymeric gellants for use herein preferably include those crystalline gellants that inherently form, or can be formulated or otherwise made to form, elongated crystalline particles having an aspect ratio greater than about 2, preferably greater than about 6. These elongated crystals preferably have an average particle size as measured along a minor axis of the elongated crystal of less than 1 μm, more preferably less than about 0.4 μm, even more preferably less than about 0.2 μm, most preferably from about 0.2 μm to about 0.002 μm. The antiperspirant compositions containing these preferred elongated crystals can be prepared by methods described herein, or by methods or techniques otherwise known in the formulation art for establishing gel matrices comprising these preferred elongated crystalline particles. The "aspect ratio" as used herein to define preferred embodiments of the compositions herein can be determined by measuring or otherwise determining the ratio of the length of the major axis of the crystalline particles to the length of the minor axis of the crystalline particles. This length ratio of the major to minor axis is characterized as the aspect ratio referred to herein. The aspect ratio can be determined by conventional or otherwise known light or electron microscopy methods, wherein the crystalline particles are measured for major and minor axis dimensions, or are otherwise observed by such methods to clearly have an apparent elongated crystalline structure with an aspect ratio substantially greater than about 2, preferably greater than about 6. It has been found that these crystalline gellants having the select aspect ratios defined herein, provide the antiperspirant compositions with a three-dimensional crystalline structure that can provide the composition with low residue performance, and a preferred elastic to viscous moduli ratio and product hardness for gel-solid embodiments of the antiperspirant composition. It is believed that this crystalline moφhology is especially effective in providing a crystalline matrix within the composition that provides for a strong interlocking gel-solid matrix network, but which also comprises crystalline particles that are sufficiently small in size so as to contribute minimally to visible residue when applied topically to the skin. It has also been found that the preferred crystalline matrix of the composition results in an overall melt profile that contributes to low residue performance. This preferred melt profile refers to the temperature at which the antiperspirant composition begins to melt, and the temperature range within which the composition is completely melted, except for any dispersed antiperspirant particulates or other high melting point components. The temperature at which the composition begins to melt is determined by measuring a Differential Scanning Calorimeter (DSC) onset temperature. The temperature range within which the composition is completely melted is determined by no additional heat infusion. Preferred embodiments of the compositions herein have a DSC onset temperature of from about 25°C to about 85°C, preferably from about 27°C to about 65°C, more preferably from about 30°C to about 60°C, even more preferably from about 35°C to about 50°C. These preferred compositions having the select melt profile provide improved cosmetics or aesthetics when applied topically to the skin, and especially provide reduced feeling of wetness, stickiness or product softness during and immediately after application. The select melt profile also helps to further reduce the visible residue index of the composition, thus further improving lower residue performance. Nucleating agent The antiperspirant compositions of the present invention preferably comprise a nucleating agent for minimizing gellant particle size, and/or for obtaining the preferred gellant particle moφhology described herein. These compositions are also preferably prepared in accordance with the following method involving the use of a nucleating agent. The nucleating agent for use in the antiperspirant composition of the present invention must be a solid material under ambient conditions and have a melting point near the melting point of the selected gellant, a solubility in the anhydrous liquid carrier that is less than the solubility of the solid non- polymeric gellant in the anhydrous liquid carrier, or be in the form of an inorganic, insoluble, micronized particulate. The nucleating agent typically crystallizes, gels, solidifies (except when the nucleating agent is a insoluble, micronized inorganic material), or acts as a nucleus (e.g. promote formation of small gellant nuclei) for the solid non-polymeric gellant just prior to, just about, or at the same time of crystallization of the gellant in the anhydrous liquid carrier. The molar ratio of the solid non-polymeric gellant to the nucleating agent must be from about 10:1 to about 1000: 1, preferably from about 10: 1 to about 100: 1. These select molar ratios will typically result in nucleating agent concentrations of from about 0.0001% to about 5%, preferably from about 0.001% to about 2%, more preferably from about 0.01% to about 1%. The nucleating agent preferably has a melting point of from about 40°C below to about 200°C above, more preferably from about 20°C below to about 100°C above the melting point of the selected gellant. The antiperspirant compositions containing the nucleating agent are preferably prepared by 1) combining the gellant, anhydrous liquid carrier and a nucleating agent as described herein, 2) heating components or the combination of components to form a solution or other homogeneous liquid or liquid dispersion, and 3) solidify the combination of components by cooling the combination to below the solidification point of the solid non-polymeric gellant to form the antiperspirant composition of the present invention. The nucleating agent for use in the antiperspirant compositions include fatty alcohols, esters of fatty alcohols, ethoxylated fatty alcohols, esters or ethers of fatty acids including waxes, and triglycerides, silica, titanium dioxide, solid polyol carboxylic acid polyesters, and mixtures thereof. Suitable fatty alcohols for use as nucleating agents include monohydric alcohols, ethoxylated fatty alcohols, and fatty alcohol esters. Specific examples of commercially available fatty alcohol nucleating agents include, but are not limited to, Unilin 550, Unilin 700, Unilin 425, Unilin 400, Unilin 350, and Unilin 325, all supplied by Petrolite. Suitable ethoxylated fatty alcohols include, but are not limited, Unithox 325, Unithox 400, and Unithox 450, Unithox 480, Unithox 520, Unithox 550, Unithox 720, Unithox 750, all of which are available from Petrolite. Non-limiting examples of suitable esters of fatty alcohols include tri-isostearyl citrate, ethyleneglycol di-12-hydroxystearate, tristearylcitrate, stearyl octanoate, stearyl heptanoate, trilaurylcitrate. Suitable fatty acid esters for use as nucleating agents include ester waxes, monoglycerides, diglycerides, triglycerides and mixtures thereof. Preferred are the glyceride esters. Non-limiting examples of suitable ester waxes include stearyl stearate, stearyl behenate, palmityl stearate, stearyl octyldodecanol, cetyl esters, cetearyl behenate, behenyl behenate, ethylene glycol distearate, ethylene glycol dipaimitate, and beeswax. Examples of commercial ester waxes include Kester waxes from Koster Keunen, Crodamol SS from Croda and Demalcare SPS from Rhone Poulenc. Preferred triglyceride nucleating agents include, but are not limited to, tristearin, tribehenate, behenyl palmityl behenyl triglyceride, palmityl stearyl palmityl triglyceride, hydrogenated vegetable oil, hydrogenated rape seed oil, castor wax, fish oils, tripalmiten, Syncrowax HRC and Syncrowax HGL-C (Syncrowax is available from Croda, Inc.). Other suitable glycerides include, but are not limited to, glyceryl stearate and glyceryl distearate. Preferably the nucleating agent is a solid polyol carboxylic acid polyester. Suitable solid polyol carboxylic acid polyesters include those which are polyol esters or polyesters wherein the carboxylic acid ester groups of the polyester comprise a combination of: (a) long chain unsaturated carboxylic acid moieties or a mixture of long chain unsaturated carboxylic acid moieties and short chain saturated carboxylic acid moieties, and (b) long chain saturated carboxylic acid moieties, the ratio of (a) to (b) being from about 1 to 15 to about 2 to 1. At least about 15%, preferably at least about 30%, more preferably at least about 50%, and most preferably at least about 60% by weight of the total carboxylic acid moieties of the polyesters are C20 or higher saturated carboxylic acid moieties. The long chain unsaturated carboxylic acid moieties are typically straight chain and contain at least about 12, preferably about 12 to about 26, more preferably about 18 to about 22 carbon atoms. The most preferred unsaturated carboxylic acids are the C 18 mono and or di unsaturated carboxylic acids. The short chain saturated carboxylic acids are typically unbranched and contain about 2 to about 12, preferably about 6 to about 12, and most preferably about 8 to about 12 carbon atoms. The long chain saturated carboxylic acids are typically straight chain and contain at least about 20, preferably about 20 to about 26, and most preferably about 22 carbon atoms. The molar ratio of Group (a) carboxylic acid moieties to Group (b) carboxylic acid moieties in the polyester molecule is from about 1 : 15 to about 2: 1, preferably about 1 :7 to about 5:3, and more preferably about 1 :7 to about 3:5. The average degree of esterification of these carboxylic acid esters is such that at least about 2 of the hydroxyl groups of the polyol are esterified. In the case of sucrose polyesters from about 7 to about 8 of the hydroxyl groups of the polyol are preferably esterified. Typically, substantially all, e.g., at least about 85%, preferably at least about 95%, of the hydroxyl groups of the polyol are esterified. Preferred polyols of the solid polyol carboxylic acid esters are sugars, including monosaccharides and disaccharides and trisaccharides, containing from about 4 to about 11 hydroxyl groups. Most preferred sugars are those which contain about 4 to about 8, more preferably about 6 to about 8 hydroxyl groups. Examples of those containing four hydroxyl groups are the monosaccharides xylose, arabinose, and combinations thereof. Suitable five hydroxyl group-containing polyols are the monosaccharides galactose, fructose, mannose, glucose, and combinations thereof. Examples of disaccharide polyols which can be used include maltose, lactose, sucrose, and combinations thereof, all of which contain eight hydroxyl groups. The preferred polyol is sucrose. Examples of long chain unsaturated carboxylic acid moieties include, but are not limited to, lauroleate, myristoleate, palmitoleate, oleate, elaidate, erucate, linoleate, linolenate, arachidonate, eicosapentaentoate. and docosahexaenoate. For oxidative stability, the mono- and diunsaturated fatty acid moieties are preferred. Examples of suitable short chain saturated carboxylic acid moieties include, but are not limited to, acetate, caproate, caprylate, caprate, and laurate. Examples of suitable long chain saturated carboxylic acid moieties include, but are not limited to, arachidate, behenate, lignocerate, and cerotate. Of course, the long chain unsaturated carboxylic acid moieties can be used singly or in mixtures with each other or in mixtures with the short chain saturated carboxylic acid moieties, in all proportions. Likewise, the long chain saturated carboxylic acid moieties can be used in combination with each other in all proportions. Mixed carboxylic acid moieties from source oils which contain substantial amounts of the desired unsaturated or saturated acids can be used as the acid moieties to prepare compounds for use as nucleating agents herein. The mixed carboxylic acids from the oils should contain at least about 30%, preferably at least about 50%, and most preferably at least about 80% of the desired unsaturated or saturated acids. For example, rapeseed oil fatty acids or soybean oil fatty acids can be used instead of pure C12-C16 unsaturated fatty acids. Hardened, i.e. hydrogenated, high erucic rapeseed oil fatty acids can be used instead of pure C20-C26 saturated acids, Preferably the C20 and higher acids, or their derivatives, e.g. methyl or other low alkyl esters, are concentrated for example by distillation. The fatty acids from palm kernal oil or coconut oil can be used as a source of C8 to C12 acids, An example of the use of source oils to make solid polyol polyesters for use in the antiperspirant compositions herein is the preparation of solid sucrose polyester, employing the fatty acids of high oleic sunflower oil and substantially completely hydrogenated high erucic rapeseed oil. When sucrose is substantially completely esterified with a 1 :3 by weight blend of the methyl esters of the fatty acids of these two oils, the resulting sucrose polyester will have a molar ratio of unsaturated C18 acid radicals to C20 and higher saturated acid radicals of about 1 : 1 and about 28.6 weight percent of the total fatty acids in the polyester will be C22 fatty acids. The higher the proportions of the desired unsaturated and saturated acids in the carboxylic acid stocks used in making the solid polyol polyester, the more efficient the ester will be in its ability to function as a nucleating agent. Examples of solid polyol carboxylic acid polyester nucleating agents for use in the antiperspirant composition herein include, but are not limited to, the octaester of raffinose in which the esterifying carboxylic acid moieties are linoleate and behenate in a 1 :3 molar ratio; the heptaester of maltose wherein the esterifying carboxylic acid moieties are sunflower seed oil fatty acids and lignocerate in a 3:4 molar ratio; the octaester of sucrose wherein the esterifying carboxylic acid moieties are oleate and behenate in a 2:6 molar ratio; and the octaester of sucrose wherein the esterfying carboxylic acid moieties are laurate, linoleate and behenate in a 1 :3:4 molar ratio. A preferred material is sucrose polyester in which the degree of esterification is 7-8, and in which the fatty acid moieties are C 18 mono- and or di-unsaturated and behenic, in a molar ratio of unsaturates:behenic of 1:7 to 3:5. A particularly preferred polyol ester nucleating agent is the octaester of sucrose in which there are about 7 behenic fatty acid moieties and about 1 oleic moiety in the molecule. The solid carboxylic acid polyesters herein can be made according to prior art known methods for preparing polyesters of polyols. See, for example U.S. Patent No. 5,306,516, to Letton et al., issued April 26, 1994; U.S. Patent No. 5,306,515, to Letton et al., issued April 26, 1994; U.S. Patent No. 5,305,514, to Letton et al., issued April 26, 1994; U.S. Patent No. 4,797,300, to Jandacek et al., issued January 10, 1989; U.S. Patent No. 3,963,699, to Rizzi et al, issued June 15, 1976; U.S. Patent No. 4,518,772, to Volpenhein, issued May 21, 1985; and U.S. Patent No. 4,517,360, to Volpenhein, issued May 21, 1985; all of which are incoφorated by reference herein in their entirety. Suitable inorganic, micronized, non-solubilized nucleating agents for use in the antiperspirant compositions include materials such as silica, titanium dioxide and combinations thereof. These materials contain submicron particles (average particle size generally less than about 1 μm) which aid in the production of small gellant crystals or particles. Preferred nucleating agents, and preferred concentrations of the nucleating agents, for use in the antiperspirant compositions include C18 succinic acid (0.1%), 1 ,9-nonanedioc acid (0.1%), Teflon (0.1%), silica (0.1%), polysiloxane copolymer (2%), sucrose octabehenate (0.5%, 0.75%, 1.0%), Unilin 350 (0.1%), Unilin 550 (0.1%), Unilin 700 (0.1%) , trihydroxystearin (0.1%) and combinations thereof. Anhydrous Liquid Carrier The anhydrous antiperspirant gel-solid stick compositions of the present invention comprise an anhydrous liquid carrier for the crystalline gellant described hereinbefore. The anhydrous liquid carrier is liquid under ambient conditions, and preferably has a low viscosity to provide for improved spreading on the skin. Concentrations of the anhydrous liquid carrier in the gel-solid stick composition will vary primarily with the type and amount of the anhydrous liquid carrier, the solid non-polymeric gellant, and the solubility of the solid non-polymeric gellant in the anhydrous liquid carrier. Preferred concentrations of the anhydrous liquid carrier are from about 10% to about 80%, preferably from about 30% to about 70%, more preferably from about 45% to about 70%, by weight of the composition. The anhydrous liquid carrier comprises one or more liquid carriers suitable for topical application to human skin. These liquid carriers may be organic, silicone-containing or fluorine-containing, volatile or non-volatile, polar or non-polar, provided that the liquid carrier forms a solution or other homogenous liquid or liquid dispersion with the selected non-polymeric gellant at the selected gellant concentration at a temperature of from about 28°C to about 250°C, preferably from about 28°C to about 100°C, preferably from about 28°C to about 78°C. The anhydrous liquid carrier has a solubility parameter of from about 3 to about 13 (cal/cm 3 ) 0 •5 , preferably from about 5 to about 1 1 (cal/cm 3 ) 0 5 , more preferably from about 5 to about 9 (cal/cm 3 ) 0 - 5 . Solubility parameters for the liquid carriers or other materials, and means for determining such parameters, are well known in the chemical arts. A description of solubility parameters and means for determining them are described by CD. Vaughan, "Solubility Effects in Product, Package, Penetration and Preservation" 103 Cosmetics and Toiletries 47-69, October 1988; and C. D. Vaughan, "Using Solubility Parameters in Cosmetics Formulation", 36 J. Soc. Cosmetic Chemists 319-333, September/October, 1988, which descriptions are incoφorated herein by reference. The anhydrous liquid carrier preferably comprises a modified or organofunctional silicone carrier selected from the group consisting of polyalkylsiloxanes, polyalkyarylsiloxanes, polyestersiloxanes, polyethersiloxane copolymers, polyfluorosiloxanes, polyaminosiloxanes, and combinations thereof. These modified silicone carriers must be liquid under ambient conditions, and have a viscosity of less than about 100,000 centistokes, preferably less than about 500 centistokes, more preferably from about 1 centistoke to about 50 centistokes, and even more preferably from about 1 centistoke to about 20 centistokes. These modified silicone carriers are generally known in the chemical arts, some examples of which are described in 1 Cosmetics, Science and Technology 27-104 (M. Balsam and E. Sagarin ed. 1972); U.S. Patent 4,202,879, issued to Shelton on May 13, 1980; U.S. Patent 5,069,897, issued to Orr on December 3, 1991; which descriptions are incoφorated herein by reference. The modified silicone carriers suitable for use in the antiperspirant gel-solid stick compositions include, but are not limited to, compounds or materials as defined hereinabove and which are generally characterized as follows: silicone polyethers or silicone glycols (such as dimethicone copolyol); silicone alkyl-linked polyethers (such as Goldschmidt EM-90 or EM-97); siloxane surfactants of a pendant/rake/comb configuration, silicone surfactants of a trisiloxane configuration, and silicone surfactants of an ABA/alpha-omega block copolymers (such as polyoxyalkylenes, polyoxyethylene or ethoxylated, polyoxyethylene/polyoxypropylene or ethoxylated/propoxylated); aromatic substituted silicone emollients (such as phenyl, alpha-methyl styryl, styryl, methylphenyl, alkylphenyl); silicone copolymers with other functional groups include: hydrogen, alkyl, methyl, amino, trifluoropropyl, vinyl, alkoxy, arylalkyl, aryl, phenyl, styryl, polyethers, esters, carboxylics; alkylmethyl siloxanes or silicone waxes (such as hexyl, octyl, lauryl, cetyl, stearyl); nonionic functional siloxane copolymers with terminal groups being silanol or trimethylsiloxy; nonionic functional siloxanes with backbone groups being trisiloxane or methicone linked; nonionic silicone surfactants; tetraethoxysilane; tetramethoxysilane; hexamethoxysilicone; oxmethoxytrisiloxane; silicone emulsifiers; silicone or siloxane resins, alkyl silicone resins, polyoxyalkylene silicone resins; MQ Resins such as Shiseido/Shin-etsu, e.g. Japanese Patent Publication JP86143760 or from Walker Chem. 6MBH (described in EP722970); alkoxysiloxanes; alkoxysilanes; methicones (polymethylalkylsiloxanes); and combinations thereof. Nonlimiting examples of suitable modified silicone carriers for use in the antiperspirant gel-solid stick compositions herein include the following modified silicones available from Dow Corning: DC-556 Cosmetic Grade Fluid (phenyl trimethicone); DC-704 Diffusion Pump Fluid (Tetramethyl-Tetraphenyl- Trisiloxane); DC-705 Diffusion Pump Fluid; DC- 1784 Emulsion; DC-AF Emulsion; DC-1520-US Emulsion; DC-593 Fluid (Dimethicone [and] Trimethylsiloxysilicate); DC-3225C Fluid (Cyclomethicone [and] Dimethicone Copolyol); DC- 190 Fluid (Dimethicone Copolyol); DC- 193 Fluid (Dimethicone Copolyol); DC- 1401 (Cyclomethicone [and] Dimethiconol); DC-5200 Fluid (Laurylmethicone Copolyol); DC-6603 Polymer Powder; DC-5640 Powder; DC-Q2-5220 (Dimethicone Copolyol); DC Q2-5324 (Dimethicone Copolyol); DC-2501 Cosmetic Wax (Dimethicone Copolyol); DC-2502 Fluid (Cetyl Dimethicone); DC-2503 Wax (Stearyl Dimethicone); DC- 1731 Volatile Fluid (Caproyl Trimethicone); DC-580 Wax (Stearoxytrimethylsilane [and] Stearyl Alcohol); DC-1-3563 (Dimethiconal); DC-X2-1286 (Dimethiconol); DC-X2-1146A (Cylcomethicone [and] Dimethiconol); DC-8820 Fluid (Amino functionalized); DC Q5-0158A wax (stearoxytrimethylsilane); DC-Q2-8220 (Trimethylsilylamodimethicone); DC-7224 (Trimethylsilylamodimethicone); DC-X2-1318 Fluid (Cyclomethicone [and] Vinyldimethicone); DC-QF1-3593A fluid (Trimethylsiloxysilicate); and combinations thereof. Other nonlimiting examples of suitable modified silicone carriers for use in the antiperspirant gel-solid stick compositions herein include the following modified silicones available from General Electric: GE SF-1023 (Dimethyl-Diphenyl-Siloxane); GE CF-1 142 (Methylphenyl Siloxane Fluid); GE SF-1153 (Dimethyl-Diphenyl-Siloxane); GE SF-1265 (Diphenyl-Dimethyl-Siloxane); GE SF-1328; GE SF-1 188 (Dimethicone copolyol); GE SF-1 188A (Silicone polyether copolymer); GE SF-1288 (silicone polyether copolymer, dimethyl-methyl 3-hydroxypropyl ethoxylated); GE SF-1318 (Methylester Siloxane); GE SF-1328 (silicone surfactant, dimethyl-methyl 3-hydroxypropyl ethoxylated- propoxylated); GE SF-1550 (methylphenyl siloxane, hexamethyl-3-phenyl-3- [[trimethylsilyl]oxy]trisiloxane); GE SF-1632 (silicone wax); GE SS-4267 (Dimethicone [and] Trimethylsiloxysilicate); and combinations thereof. Other nonlimiting examples of suitable modified silicone carriers for use in the antiperspirant gel-solid stick compositions herein include the following modified silicones available from Goldschmidt: Abil EM-90 (silicone emulsifier); Abil EM-97 (polyether siloxane); Abil Wax 9810 (silicone wax or C24- 28 methicone); Abil Wax 2434 (Stearoxy Dimethicone); Abil Wax 9800D (Stearyl Dimethicone); Tegomer H-Si 21 1 1, H-Si 231 1, A-Si 2120, A-Si 2320, C-Si 2141, C-Si 2341, E-Si 2130, E-Si 2330, V- Si 2150, V-Si 2550, H-Si 6420, H-Si 6440, H-Si 6460 (Alpha-Omega Dimethicone Copolymers); and combinations thereof. Other nonlimiting examples of suitable modified silicone carriers for use in the antiperspirant gel-solid stick compositions herein include the following: Masil 756 from PPG Industries (Tetrabutoxypropyl Trisiloxane); bis-phenyihexamethicone (available as Silbione Oils 70633 V30 from Rhone-Poulenc); Silbione Oils 70646 (dimethicone copolyols from Rhone-Poulenc); Silicone L-71 1, L- 720, L-721 and L722 (dimethicone copolyols from Union Carbide); Silicone L-7000, L-7001, L-7002, L- 7004, L-7500, L-7600, L-7602, L-7604, L-7605, and L-7610 (dimethicone copolyols from Union Carbide); Unisil SF-R (dimethiconol from UPI); Silicate Cluster from Olin (Tris[tributoxysiloxy]methylsilane); silicone copolymer F-754 (dimethicone copoly from SWS Silicones); and combinations thereof. The anhydrous liquid carrier preferably comprises a volatile silicone carrier. These volatile silicone carriers may be cyclic, linear or branched chain silicones having the requisite volatility defined herein. Non-limiting examples of suitable volatile silicones are described in Todd et al, "Volatile Silicone Fluids for Cosmetics", Cosmetics and Toiletries, 91 :27-32 (1976), which descriptions are incoφorated herein by reference. Preferred among these volatile silicones are the cyclic silicones having from about 3 to about 7, more preferably from about 4 to about 5, silicon atoms. Most preferably are those which conform to the formula: wherein n is from about 3 to about 7, preferably from about 4 to about 5, most preferably 5. These volatile cyclic silicones generally have a viscosity value of less than about 10 centistokes. All viscosity values described herein are measured or determined under ambient conditions, unless otherwise specified. Suitable volatile silicones for use herein include, but are not limited to, Cyclomethicone D-5 (commercially available from G. E. Silicones); Dow Corning 344, and Dow Corning 345 (commercially available from Dow Corning Coφ.); GE 7207, GE 7158 and Silicone Fluids SF-1202 and SF-1173 (available from General Electric Co.); SWS-03314, SWS-03400, F-222, F-223, F-250, F-251 (available from SWS Silicones Coφ.); Volatile Silicones 7158, 7207, 7349 (available from Union Carbide); Masil SF-V ( available from Mazer); and combinations thereof. The anhydrous liquid carrier may also comprise a non-volatile silicone carrier other than or in addition to the preferred modified silicone carriers described hereinbefore. These non-volatile silicone carriers are preferably linear silicones which include, but are not limited to, those which conform to either of the formulas: CH, wherein n is greater than or equal to 1. These linear silicone materials will generally have viscosity values of up to about 100,000 centistoke, preferably less than about 500 centistoke, more preferably from about 1 centistoke to about 200 centistoke, even more preferably from about 1 centistoke to about 50 centistoke, as measured under ambient conditions. Examples of non-volatile, linear silicones suitable for use in the antiperspirant compositions include, but are not limited to, Dow Corning 200, hexamethyldisiloxane, Rhodorsil Oils 70047 available from Rhone-Poulenc, Masil SF Fluid available from Mazer, Dow Corning 225, Dow Corning 1732, Dow Corning 5732, Dow Corning 5750 (available from Dow Corning Coφ.); SF-96, SF-1066 and SF 18(350) Silicone Fluids (available from G.E. Silicones); Velvasil and Viscasil (available from General Electric Co.); and Silicone L-45, Silicone L530, Silicone L-531 (available from Union Carbide), and Siloxane F-221 and Silicone Fluid SWS- 101 (available from SWS Silicones). The anhydrous liquid carrier may further comprise, but is preferably substantially free of, organic, water-immiscible, polar liquid carriers or solvents. It has been found that the antiperspirant and deodorant efficacy of the gel-solid stick compositions are improved by minimizing or eliminating the amount of polar, organic, water-immiscible, liquid carriers or solvents in the composition. In this context, the term "substantially free" means that the gel-solid stick compositions preferably contain less than 7%, more preferably less than about 3%, even more preferably zero percent, by weight of an organic, water- immiscible, polar liquid carrier or solvent. These polar solvents are liquid under ambient conditions and include mono and polyhydric alcohols, fatty acids, esters of mono and dibasic carboxylic acids with mono and polyhydric alcohols, polyoxyethylenes, polyoxypropylenes, polyalkoxylates ethers of alcohols, and combinations thereof, provided that such solvents are also water-immiscible liquids under ambient conditions. Examples of some anhydrous liquid, water-immiscible, polar organic liquid carriers or solvents are described in Cosmetics, Science, and Technology, Vol. 1, 27-104, edited by Balsam and Sagarin (1972); U.S. Patent 4,202,879 issued to Shelton on May 13, 1980; and U.S. Patent 4,816,261 issued to Luebbe et al. on March 28, 1989, which descriptions are incoφorated herein by reference. The anhydrous liquid carrier may comprise anhydrous, water-miscible, polar organic liquid carriers or solvents, examples of which include short chain alcohols such as ethanol. These and other polar organic carriers or solvents can be used as co-solvents for the solid non-polymeric gellant component of the antiperspirant gel-solid stick compositions herein. Non-limiting examples of polar co- solvents suitable for use herein are described in U.S. Patent 5,429,816. Other suitable polar co-solvents include those described hereinabove, which are preferably water-immiscible organic solvents, and other co-solvents such as phthalate co-solvents, benzoate co-solvents, cinnamate esters, secondary alcohols, benzyl acetate, phenyl alkane and combinations thereof. The anhydrous liquid carrier may comprise other non-polar carriers such as mineral oil, petrolatum, isohexadecane, isododecane, various hydrocarbon oils such as the Isopar or Noφar series available from Exxon Coφ. or Permethyl series available from Persperse, and any other polar or non- polar, water-miscible, organic carrier liquid or solvent known or otherwise safe and effective for topical application to human skin. The anhydrous liquid carrier may also comprise fluorochemicals such as fluorosurfactants, fluorotelemers, and perfluoropolyethers, some examples of which are described in Cosmetics & Toiletries, Using Fluorinated Compounds in Topical Preparations, Vol. I l l, pages 47-62, (Oct. 1996) which description is incoφorated herein by reference. More specific examples of such liquid carriers include, but are not limited to, perfluoropolymethyl isopropyl ethers, perfluoropolypropylethers, acrylamide fluorinated telomer, fluorinated amide surfactants, perfluorinated thiol surfactants. Other more specific examples include, but are not limited to, the polyperfluoroisopropyl ethers available from Dupont Performance Chemicals under the trade name Fluortress ® PFPE oils, and the series fluorosurfactants from Dupont Performance Chemicals under the trade name Zonyl ® Fluorosurfactants. Optional Components The antiperspirant compositions of the present invention may further comprise one or more optional components which may modify the physical, chemical or aesthetic characteristics of the compositions or serve as additional "active" components when deposited on the skin. The compositions may also further comprise optional inert ingredients. Many such optional materials are known in the antiperspirant art and may be used in the antiperspirant compositions herein, provided that such optional materials are compatible with the essential materials described herein, or do not otherwise unduly impair product performance. Non-limiting examples of optional materials include active components such as bacteriostats and fungiostats, and "non-active" components such as colorants, perfumes, emulsifiers, chelants, distributing agents, preservatives, residue masking agents, process aides such as viscosity modifiers, and wash-off aids. Examples of such optional materials are described in U.S. Patent 4,049,792, Elsnau, issued September 20, 1977; Canadian Patent 1,164,347, Beckmeyer et al, issued March 27, 1984; U.S. Patent 5,019,375, Tanner et al, issued May 28, 1991; and U.S. Patent 5,429,816, Hofrichter et al, issued July 4, 1995; which descriptions are incoφorated herein by reference. The antiperspirant gel-solid stick compositions of the present invention can also be formulated to comprise other dispersed solids or other materials in addition to or in place of the particulate antiperspirant active. Such other dispersed solids or other materials include any material known or otherwise suitable for topical application to human skin. The antiperspirant gel-solid stick compositions can also be formulated as gel-solid stick compositions which contain no antiperspirant or other active material, particulate or otherwise. The antiperspirant compositions of the present invention can also be formulated as creams, lotions, soft-gels and similar other compositions comprising select nucleating agents, wherein the compositions have a product hardness of less than about 500 gram-force, preferably from about 20 gram- force to about 500 gram-force. It is understood, however that these softer compositions do not have the preferred rheology profile as defined herein. Method of Manufacture The antiperspirant gel-solid stick compositions of the present invention may be prepared by any known or otherwise effective technique, suitable for providing an antiperspirant gel-solid stick composition having the requisite crystalline matrix and other product characteristics described herein. Such methods involve formulation of the essential components of the composition to form a gel-solid having the requisite elastic to viscous moduli ratio, product hardness, and visible residue index, wherein the crystalline matrix within the composition comprises elongated non-polymeric gellant crystals having an aspect ratio of greater than about 2, preferably greater than about 6, and an average particle diameter that is minimized (preferably to less than about 1 μm) through techniques directed to minimizing crystalline particle size in a composition. Crystalline particle size in the preferred embodiments of the present invention can be determined by techniques well known in the art, which includes light or electron microscopy of the composition, wherein the composition is formulated for analysis puφoses without particulate antiperspirant active or other solid particulates. Without such reformulation, it is more difficult to directly determine and distinguish crystalline gellant particle size and moφhology from the particle size and moφhology contributed from other non-gellant particulates. The reformulated composition is then evaluated by light or electron microscopy or other similar method. Techniques for preparing the antiperspirant gel-solid stick compositions of the present invention include those methods suitable for formulating compositions containing small gellant crystalline particles. Suitable techniques for minimizing crystalline gellant particle size include the use of nucleating agents, formulation with select carriers or gellants or carrier/gellant combinations, controlling rates of crystallization including controlling formulation, controlling process flow rate, and processing temperatures, and other methods described herein. All such methods should be applied to the formulation to control or minimize gellant crystal particle size, and/or to form the desired elongated crystalline particles, to thus form the desired crystalline matrix of the composition. Method of Use The antiperspirant gel-solid stick compositions may be applied topically to the axilla or other area of the skin in an amount effective to treat or reduce perspiration wetness and malodor. The composition is preferably applied in an amount ranging from about 0.1 gram to about 20 grams, more preferably from about 0.1 gram to about 10 grams, even more preferably from about 0.1 gram to about 1 gram, to the desired area of the skin. The compositions are preferably applied to the axilla or other area of the skin, one or two times daily, preferably once daily, to achieve effective antiperspirant and malodor control over an extended period. EXAMPLES The following non-limiting examples illustrate specific embodiments of the antiperspirant gel- solid stick compositions of the present invention, including methods of manufacture and use. Each of the exemplified compositions are prepared by combining all of the listed components except the antiperspirant active and other materials such as perfumes. The combined components are heated to about 100°C with agitation to form a hot liquid, after which all other materials are added to the heated liquid. The heated liquid is allowed to cool with agitation until just before the point of solidification, at which point the cooled, liquid composition is filled into applicator packages and allowed to cool and solidify to the requisite product hardness. Each of the exemplified compositions form a crystalline gel matrix containing crystalline particles having an aspect ratio of greater than about 6, and an average crystalline gellant particle size of less than about 1 μm. Each of the exemplified compositions also have a visible residue index of between about 1 1 and about 30 L-value, a product hardness of between about 500 and 5,000 gram-force, and a G'/G" ratio of between about 0.1 and about 100. Each of the exemplified antiperspirant compositions are applied topically to the axilla area of the skin, in accordance with the methods of use described herein, and provide improved low residue performance, efficacy and aesthetics. Component Example Number I II III iv Cyclomethicone D5 1 45.3 45.8 19.7 19.7 Octyldodecanol 2 16.4 16.4 ~ Petrolatum 3 — 44.3 46.3 12-Hydroxystearic Acid 4 8.0 8.0 8.0 7.0 C20-40 alcohols 5 0.5 - Sucrose Polyester 6 1.0 1.0 1.0 - C20-40 Pareth-10 7 1.25 1.25 — C20-40 Pareth-40 8 1.25 1.25 ~ Stearyl Alcohol 9 - 1.0 1.0 Perfume 0.1 0.1 - Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 26.0 Disodium EDTA 1 1 0.2 0.2 — Residue (L-value) 25.0 24.0 23.0 27.0 Hardness (gram-force) 1,300 1,250 1250 990 Component Example Number V VI VII VIII Cyclomethicone D5 1 45.3 44.3 43.3 42.3 Octyldodecanol 2 16.5 16.5 16.5 16.5 12-Hydroxystearic Acid 4 8.0 9.0 10.0 11.0 C20-40 alcohols 5 0.5 0.5 0.5 0.5 Sucrose Polyester 6 1.0 1.0 1.0 1.0 C20-40 Pareth-10 7 1.25 1.25 1.25 1.25 C20-40 Pareth-40 8 1.25 1.25 1.25 1.25 Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 26.0 Disodium EDTA" 0.2 0.2 0.2 0.2 Residue (L-value) 25.0 27.0 27.5 28.0 Hardness (gram-force) 1 170 1450 1660 1910 Component Example Number Cyclomethicone D5 1 49.7 49.7 49.7 49.7 Octyldodecanol 2 14.0 14.0 14.0 14.0 12-Hydroxystearic Acid 4 7.0 7.0 7.0 7.0 C20-C40 Alcohols 5 0.5 0.5 0.5 0.5 C20-40 Pareth-10 7 1.25 1.25 1.25 1.25 C20-40 Pareth-40 8 1.25 1.25 1.25 1.25 Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 26.0 Disodium EDTA 1 1 0.2 0.2 0.2 0.2 2-Stearylbutanedioc Acid 12 0.1 - - ~ 1 ,9-Nonanedioc Acid 13 ~ 0.1 - - Polyfluorocarbon 1 - ~ 0.1 - Silica 15 - ~ ~ 0.1 Residue (L-value) 29.0 30.0 29.0 27.5 Hardness (gram-force) 1200 1200 1110 1150 Component Example Number XIII XIV XV XVI Cyclomethicone D5 1 49.3 48.8 49.05 45.3 Octyldodecanol 2 14.0 14.0 14.0 16.5 12-Hydroxystearic Acid 4 7.0 7.0 7.0 8.99 C20-C40 Alcohols 5 0.5 0.5 0.5 0.5 C20-40 Pareth-10 7 1.25 1.25 1.25 1.25 C20-40 Pareth-40 8 1.25 1.25 1.25 1.25 Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 26.0 Disodium EDTA 1 1 0.2 0.2 0.2 0.2 Sucrose Polyester 6 0.5 1.0 0.75 0.1 Residue (L-value) 27.5 25.0 28.0 27.0 Hardness (gram-force) 1480 : 150 1 100 2700 Component Example Number XVII XVIII XIX Cyclomethicone D5 1 49.7 49.7 49.7 Octyldodecanol 2 14.0 14.0 14.0 12-Hydroxystearic Acid 4 7.0 7.0 7.0 C20-C40 Alcohols 5 0.5 0.5 0.5 C20-40 Pareth-10 7 1.25 1.25 1.25 C20-40 Pareth-40 8 1.25 1.25 1.25 Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 Disodium EDTA 1 1 0.2 0.2 0.2 C20-C40 Alcohols 16 0.1 — — C20-C40 Alcohols 17 - 0.1 — C20-C40 Alcohols 18 ~ - 0.1 Residue (L-value) 28.5 29.0 29.0 Hardness (gram-force) 1140 1 140 1050 Component Example Number XX XXI XXII Cyclomethicone D5 1 49.7 49.7 49.7 Octyldodecanol 2 14.0 14.0 14.0 12-Hydroxystearic Acid 4 7.0 7.0 7.0 C20-C40 Alcohols 5 0.5 0.5 0.5 C20-40 Pareth-10 7 1.25 1.25 1.25 C20-40 Pareth-40 8 1.25 1.25 1.25 Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 Disodium EDTA 1 1 0.2 0.2 0.2 Trihydroxystearin 19 0.1 — — Stearyl Alcohol 9 — 0.1 — Cetearyl Alcohol 20 ~ ~ 0.1 Residue (L-value) 30.0 27.0 27.0 Hardness (gram-force) 1000 990 990 Component Example Number XXIII XXIV XXV XXVI Cyclomethicone D5 1 45.3 45.8 19.7 19.7 Octyldodecanol 2 16.4 16.4 Petrolatum 3 ~ 44.3 45.3 N-lauroyl-glutamic acid dibutyl amide 21 8.0 8.0 8.0 12-Hydroxystearic Acid 4 - 8.0 C20-40 alcohols 5 0.5 .. Sucrose Polyester 6 1.0 1.0 1.0 C20-40 Pareth-10 7 1.25 1.25 C20-40 Pareth-40 8 1.25 1.25 Stearyl Alcohol 9 ~ 1.0 1.0 Perfume 0.1 0.1 Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 26.0 Disodium EDTA" 0.2 0.2 -- - Residue (L-value) 25.0 24.5 22.0 19.0 Hardness (gram-force) 1000 1000 1250 1500 Component Example Number XXVII XXVIII XXIX XXX Cyclomethicone D5 1 45.3 45.8 36.3 60.0 Octyldodecanol 2 16.4 16.4 16.4 — 2 dodececyl-N.N'-dibutylsuccinamide 22 8.0 — — — N-isopropy 1- 12-hydroxystearamide 23 — 8.0 — — 12-Hydroxystearic Acid 4 — ~ 16.0 8.0 C20-40 alcohols 5 — 0.5 0.5 — Sucrose Polyester 6 1.0 1.0 2.0 1.0 C20-40 Pareth-10 7 1.25 1.25 1.25 ~ C20-40 Pareth-40 8 1.25 1.25 1.25 — Perfume 0.1 0.1 0.1 — Al Zr tri chlorohydrex glycinate 10 26.0 26.0 26.0 26.0 Disodium EDTA 1 1 0.2 0.2 0.2 ~ Polyether siloxane 24 Residue (L-value) 25.0 28.0 24.0 29.5 Hardness (gram-force) 1000 1500 2500 1050 1 - Dow Corning 245 Fluid; General Electric SF-1202 2 - Jarchem Jarcol 1-20 3 - Witco White Perfecta 4 - Acme Hardesty 5 - Petrolite Unilin 425 6 - The sucrose polyester is a sucroseoctaester esterified predominately with behenic acid moieties 7 - Petrolite Unithox 450 8 - Petrolite Unithox 480 9 - Witco 10 - Supplied by Westwood Chemical Corporation 11 - Supplied by Ciba-Geigy 12 - Humphrey Chemicals 13 - Aldrich 14 - Aldrich 15 - Cabot 16 - Petrolite Unilin 350 17 - Petrolite Unilin 550 18 - Petrolite Unilin 700 19 - N Chemicals 20 - Witco - Ajinimoto - Procter & Gamble - Starks Associates - Goldschmidt EM-97

Claims: What is claimed is: 1. An anhydrous antiperspirant gel-solid stick composition comprising: (a) from 0.5% to 60% by weight of particulate antiperspirant active; (b) from 1% to 15% by weight of a solid non-polymeric gellant; (c) from 10% to 80% by weight of an anhydrous liquid carrier having an average solubility parameter of from 3 to 13 (cal/cm^)^; and (d) from 0.0001% to 5%, preferably from 0.01% to 2%, by weight of a solid nucleating agent; wherein the composition has a molar ratio of solid non-polymeric gellant to solid nucleating agent of from 10: 1 to 1000: 1, preferably from 10:1 to 100:1, and wherein the composition has a hardness of from 500 gram-force to 5000 gram-force, a visible residue index of from 1 1 to 30 L- value, and an elastic to viscous moduli ratio of from 0.1 to 100. 2. An anhydrous antiperspirant composition comprising: (a) from 0.5% to 60% by weight of particulate antiperspirant active; (b) from 1% to 15% by weight of a solid non-polymeric gellant; (c) from 10% to 80% by weight of an anhydrous liquid carrier having an average solubility parameter of from 3 to 13 (cal/cm^)^; and (d) from 0.0001% to 5% by weight of a solid nucleating agent; wherein the composition has a hardness of from 20 gram-force to 500 gram-force. 3. The composition of Claim 1 or 2 wherein the solid non-polymeric gellant is selected from the group consisting of 12-hydroxystearic acid, esters of 12-hydroxystearic acid, amides of 12- hydroxystearic acid, C20 to C40 fatty acids, n-acyl amino acid amides and n-acyl amino acid esters of glutamic acid, lysine, glutamine, and aspartic acid, disubstituted and branched monoamides, monosubstituted and branched diamides, triamides, and mixtures thereof, preferably 12-hydroxystearic acid and mixtures thereof. 4. The composition of any one of the preceding claims wherein the anhydrous liquid carrier is selected from the group consisting of cyclic polydimethylsiloxanes, linear polydimethylsiloxanes, polyalkylsiloxanes, polyalkylarylsiloxanes, polyestersiloxanes, polyethersiloxane copolymers, polyflurosiloxanes, polyaminosiloxanes, isohexadecane, isododecane, mineral oil, petrolatum, and mixtures thereof. 5. The composition of any one of the preceding claims wherein the solid nucleating agent is selected from the group consisting of fatty alcohols, fatty acid esters, fatty acid ethers, silica, titanium dioxide, solid polyol carboxylic acid polyesters, and mixtures thereof. 6. The composition of any one of the preceding claims wherein the fatty alcohol is selected from the group consisting of monohydric alcohols, ethoxylated fatty alcohols, fatty alcohol esters, and mixtures thereof. 7. The composition of any one of the preceding claims wherein the fatty acid ester is selected from the group consisting of stearyl stearate, stearyl behenate, palmityl stearate, stearyl octyldodecanol, cetyl esters, cetearyl behenate, behenyl behenate, ethylene glycol distearate, ethylene glycol dipalmitate, beeswax, tristearin, tribehenate, behenyl palmityl, behenyl triglyceride, palmityl stearyl, palmityl triglyceride, hydrogenated vegetable oil, hydrogenated rape seed oil, castor wax, fish oils, tripalmiten, glyceryl stearate, glyceryl distearate, and mixtures thereof. 8. The composition of any one of the preceding claims wherein the solid polyol carboxylic acid polyester has a polyol moiety and at least 2 carboxylic acid moieties wherein the polyol moiety is a sugar, preferably sucrose, containing at least 4 hydroxyl groups, preferably from 4 to 8 hydroxyl groups, wherein the carboxylic acid moiety consists essentially of (a) C12 or higher, preferably C12 to C26, unsaturated carboxylic acid moieties, and (b) C20 or higher, preferably C20 to C26, saturated carboxylic acid moieties, preferably behenic moieties, the molar ratio of (a) to (b) being from about 1 :7 to about 3:5, and wherein at least 2 of the hydroxyl groups of the polyol moiety are esterified with carboxylic acid moieties, and wherein the solid polyol carboxylic acid polyester is a sucrose octaester having about one oleoc moiety and about seven behenic moieties. 9. A method for making an anhydrous antiperspirant gel-solid stick composition, which method comprises the steps of (a) combining the following components: (i) from 0.5% to 60% by weight of particulate antiperspirant active; (ii) from 1% to 15% by weight of a solid non-polymeric gellant; (iii) from 10% to 80% by weight of an anhydrous liquid carrier having an average solubility parameter of from 3 to 13 (cal/cm^)^-^; and (iv) from 0.0001% to 5.0% by weight of a solid nucleating agent; (b) liquefying the solid non-polymeric gellant and the solid nucleating agent by heating the composition above the melt point of the solid non-polymeric gellant and the solid nucleating agent; and (c) solidifying the liquefied gellant in the presence of the nucleating agent to form the anhydrous antiperspirant gel-solid stick composition. 10. A method for making an anhydrous antiperspirant gel-solid stick composition, which method comprises the steps of (a) combining the following components: (i) from 0.5% to 60% by weight of particulate antiperspirant active; (ii) from 1% to 15% by weight of a solid non-polymeric gellant; (iii) from 10% to 80% by weight of an anhydrous liquid carrier having an average solubility parameter of from 3 to 13 (cal cm-')" ^; and (iv) from 0.0001% to 5.0% by weight of a solid, inorganic, insoluble, micronized nucleating agent; (b) liquefying the solid non-polymeric gellant by heating the composition above the melt point of the solid non-polymeric gellant; and (c) solidifying the liquefied gellant in the presence of the nucleating agent to form the anhydrous antiperspirant gel-solid stick composition.

Inventors: GUSKEY GERALD JOHN, MOTLEY CURTIS BOBBY, TZEGHAI GHEBRE EGZIABHER, GUSKEY, GERALD, JOHN, MOTLEY, CURTIS, BOBBY, TZEGHAI, GHEBRE, EGZIABHER
Applicants: PROCTER & GAMBLE, THE PROCTER & GAMBLE COMPANY
Application year: 1997
Main classification: A61K7
IPC codes: A61K8, A61Q15, C08L83